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Objective: A review of our recent experience of operating on infants weighing
2 kg or less who had congenital heart disease was performed to determine
the outcome of early surgical repair or palliation. Methods: A retrospective
review of hospital records was performed for infants who weighed 2 kg or
less and who were identified to have undergone cardiac operation at our
institution January 1992 to June 1997. The data collected included age,
weight, gestational age, cardiac diagnosis, surgical procedure, and outcome
measures such as length of stay, morbidity, and mortality rate. Outpatient
charts were reviewed for follow-up survival and cardiac status. Results:
Thirty-three operations were performed on 30 patients. Median age at
operation was 19.5 days (1 to 140 days), and median weight was 1.8 kg (1.1
to 2.0 kg). Cardiac diagnoses varied, with coarctation of the aorta and
tetralogy of Fallot most common. Twenty-four patients were born at 37 or
fewer weeks’ gestation. Hospital survival was 83% with no difference in
mortality rates based on age, weight, or type of surgical procedure.
Premature infants tended to have worse hospital survival. Median postop-
erative length of stay was 39 days (6 to 122 days). Median duration of
mechanical ventilation in survivors was 6 days (2 to 24 days). Neurologic
complications were documented in eight patients. Of the 25 hospital
survivors, 20 (80%) are alive with good cardiac status at a mean follow-up
of 13 months. Conclusion: Cardiac operations in a selected group of infants
weighing 2 kg or less can provide acceptable hospital survival. In most
instances, complete repair is possible with good medium-term outcome in
the survivors. Investigation into neurologic outcomes in these patients is
warranted. (J Thorac Cardiovasc Surg 1998;116:28-35)
Cardiac surgery in the neonate with congenitalheart disease has progressed dramatically in the
past two and a half decades. Inspired by a report of
successful correction of congenital heart lesions in
infants by Barratt-Boyes and associates1 in 1972,
surgeons have made great strides toward making
surgical correction of most congenital heart lesions
achievable in the neonate.2-9 However, low-birth-
weight infants with congenital heart disease con-
tinue to challenge the intellectual and technical
skills of those who care for them. The advent of
alprostadil (prostaglandin E1) for the resuscitation
of neonates with critical heart disease allows an
almost indefinite means of palliation.10 Medical
palliation with alprostadil for an extended period of
time may yield somatic growth in low-birth-weight
infants, although this strategy is controversial.
We reviewed our experience in operating on
low-birth-weight infants with congenital heart dis-
ease. The objective was to determine the outcome of
prompt surgical repair or palliation in this subgroup
of patients in an attempt to determine the optimal
management strategy.
Patients and methods
Study population. The pediatric cardiovascular data-
base at The Mount Sinai Medical Center was searched for
all infants undergoing operations for congenital heart
disease from January 1992 to June 1997. Infants whose
weight was 2.0 kg or less at the time of operation were
eligible for the study. Infants undergoing ligation of a
patent ductus arteriosus as their primary surgical proce-
dure were excluded. Two additional patients were ex-
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cluded because they had had a cardiac operation else-
where before being seen at our institution. A retrospective
review of the hospital and outpatient charts, echocardio-
gram reports, and cardiac catheterization reports was
performed for the remaining 30 patients. Patients’ ages
and weights at operation and cardiac diagnoses are pre-
sented in Table I. Age at operation was 1 to 140 days
(median, 19.5 days), and weight was 1.1 to 2.0 kg (median,
1.8 kg). Cardiac diagnoses included coarctation of the
aorta (eight patients) and tetralogy of Fallot (TOF; five
patients). Eight patients had a variant of single ventricle
that would eventually require Fontan palliation. Alpros-
tadil therapy was used before the operation in 22 patients
to maintain ductal patency. Nine patients were born at our
institution. The remainder were referred to our institution
at ages 1 to 95 days (median, 6 days). An operation was
performed 1 to 45 days (median, 11 days) after admission
to our institution. Three patients underwent two separate
cardiac operations while weighing 2.0 kg or less.
Gestational age at birth was available for 29 patients,
with the range for this group 28 to 40 weeks (median, 33
weeks). Twenty-four of the 29 patients were born prema-
turely (gestational age, 37 weeks or less) and had weights
that were appropriate for gestational age. Of the five term
infants, one was from a twin gestation; one was born of a
mother with severe insulin-dependent diabetes mellitis
with vasculopathy; one had multiple congenital anomalies
but no defined syndrome, and two had no known expla-
nation for being small for gestational age. Of the entire
patient group, four patients were from twin gestations;
two patients had heterotaxy syndrome, and one patient
each had trisomy 21, trisomy 18, a deletion at the 22q11
locus, nonimmune hydrops fetalis, and the VACTERL
association. Five additional patients had a combination of
major noncardiac congenital anomalies, including renal,
gastrointestinal, skeletal, and abdominal wall abnormali-
ties.
Preoperative strategies. When first seen at our institu-
tion and before the operation, the hemodynamic status of
each infant was stabilized. This included the use of
alprostadil in patients with ductus-dependent heart le-
sions. Major organ system insults were given time to
improve. Nutritional status was optimized with either
enteral or parenteral supplementation. An operation was
never delayed solely for the purpose of somatic growth.
Surgical procedure. All complete repairs and stage I
palliation for hypoplastic left heart syndrome (HLHS)
were classified as type A procedures. In newborns who
Table I. Age, weight, diagnosis, procedure, and hospital survival
Patient Age (days) Weight (kg) Diagnosis Procedure Survival
1 20 1.7 Coarctation/VSD Coarctation repair, PAB f
complete repair
1
2 25 1.4 TOF/PA BTS 1
3 4 1.3 TAPVR, obstructed Repair 1
4 19 2.0 TOF Repair 1
5 34 1.5 Coarctation Repair 1
6 1 1.4 TOF BTS 1
7 4 1.9 TAPVR/VSD Repair 1
8 16 1.9 HLHS Stage I 2
9 10 1.1 Coarctation/VSD Coarctation repair 2
10 140 1.6 HLHS Stage I 1
11 13 1.8 Coarctation/VSD Repair 1
12 32 1.9 Coarctation Repair 1
13 30 2.0 Truncus arteriosus Palliation 1
14 43 2.0 Unbalanced AVC PAB 1
15 8 1.9 HLHS Stage I 1
16 22 2.0 TGA/IVS PAB f repair 1
17 10 1.8 Coarctation/VSD Repair 1
18 11 1.9 Truncus arteriosus Repair 1
19 8 1.8 TGA/IVS Repair 2
20 27 2.0 TOF Repair 1
21 20 1.9 Heterotaxy Stage I 1
22 16 1.9 Coarctation Repair 1
23 38 1.8 Heterotaxy BTS 1
24 22 2.0 Coarctation Repair 1
25 22 1.4 Unbalanced AVC PAB f DKS/BTS 2
26 5 1.6 PA/IVS BTS 1
27 44 1.1 L-TGA/VSD PAB 1
28 24 2.0 TOF/PA BTS 2
29 14 1.5 TAPVR/VSD Repair 1
30 7 1.7 PA/IVS BTS 1
AVC, Atrioventricular canal; BTS, Blalock-Taussig shunt; DKS, Damus-Kaye-Stansel; IVS, intact ventricular septum; PA, pulmonary atresia; PAB, pulmonary
artery band. 1, Survival; 2, mortality.
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were not candidates for eventual biventricular repair, a
systemic–pulmonary artery shunt for inadequate pulmo-
nary blood flow and a pulmonary artery band for excessive
pulmonary blood flow were also considered type A pro-
cedures. Palliative procedures performed in patients who
would likely have undergone complete repair had they
been larger in size were classified as type B. Thirty-three
procedures were performed on 30 patients (Table I).
There were 16 open heart operations and 17 closed heart
operations performed. Of the 30 initial operations, 22
were type A (definitive procedures) and 8 were type B
(palliations). One patient with transposition of the great
arteries (TGA) with intact ventricular septum underwent
pulmonary artery banding followed by an arterial switch
operation. The pulmonary artery banding was classified as
a type A procedure because it was not an attempt to
palliate the cardiac defect but was part of a rapid,
two-stage approach to a definitive repair.12 One patient
with coarctation and ventricular septal defect (VSD)
initially underwent coarctation repair and pulmonary ar-
tery banding and could not be weaned from mechanical
ventilation. He underwent VSD closure and pulmonary
artery debanding 1 month after the initial procedure. One
patient with a single ventricle and excessive pulmonary
blood flow (unbalanced atrioventricular canal) initially
underwent pulmonary artery banding which failed to
control symptoms of congestive heart failure. She subse-
quently underwent a Damus-Kaye-Stansel anastomosis
and modified Blalock-Taussig shunt 6 weeks after the
initial procedure. Type B procedures included a systemic–
pulmonary artery shunt for TOF, a pulmonary artery band
for an atrioventricular canal defect or VSD, coarctation
repair with pulmonary artery banding for coarctation with
VSD, and palliation of truncus arteriosus whereby the
pulmonary arteries were isolated from the truncus and a
systemic–pulmonary artery shunt was placed to provide
pulmonary blood flow.
Intraoperative management. All open procedures were
done through a sternotomy. Standard aortic and venous
cannulas were used, and single venous cannulation was
used in all patients. The cardiopulmonary bypass (CPB)
circuit was primed with electrolyte solutions (Plasma-
Lyte; Baxter Healthcare Corp., Deerfield, Ill.) and whole
blood to achieve a hematocrit value of 20% to 25%. Pump
flow was calculated to be 150 to 175 ml/kg/min. Alpha-stat
strategy was used. Once CPB was initiated, hypothermia
was induced to bring the blood temperature to 10° C.
Before crossclamping, a single dose of potassium chloride,
1.5 to 2.0 mEq/kg, was introduced into the pump circuit to
induce diastolic arrest. Hypothermic circulatory arrest was
used intermittently or as one single period up to 72
minutes. Before circulatory arrest, the esophageal temper-
ature was brought down to 12° C and the head was packed
in ice. Hemofiltration and addition of whole blood were
carried out on rewarming to produce a hematocrit level
above 40%. Recently, modified ultrafiltration was also
used. Patients were weaned from CPB with low-dose
epinephrine or dopamine, which were generally main-
tained until extubation.
Postoperative management. Sedation and analgesia
consisted of a continuous infusion of fentanyl at a dose of
10 to 15 mg/kg/hr for all patients for at least the first 24
hours after the operation. Later, sedation and analgesia
varied according to the patients’ needs. Most infants who
required prolonged sedation received fentanyl alone or a
combination of fentanyl and midazolam while intubated.
Neuromuscular blockade was accomplished with intermit-
tent boluses of vecuronium while the patient was attached
to the mechanical ventilator.
Ventilation was accomplished with the Servo Ventilator
900c (Siemens-Elema AB, Solna, Sweden) in all patients
initially. Patients received ventilation in the volume con-
trol mode with a tidal volume of 15 to 20 ml/kg. The
minimum inspired oxygen fraction that provided accept-
able arterial oxygen saturations was used. Supplemental
oxygen was used when necessary as a pulmonary vasodi-
lator. Ventilator parameters were adjusted to achieve a
carbon dioxide tension considered optimal to manipulate
the pulmonary vascular resistance.
All patients received perioperative antibiotics. Ac-
counting for the skin flora unique to newborns, the
standard antibiotic regimen consisted of a combination of
nafcillin and cefotaxime. Patients admitted with an open
chest received vancomycin and ceftazidime therapy.
Postoperative management in these infants was other-
wise consistent with protocols for managing other neo-
nates after congenital heart operations in our institution.
Fluid and electrolyte management included frequent mea-
surements of ionized calcium and potassium. The number
of laboratory specimens obtained was similar to that of
other infants recovering from heart operations in the
intensive care unit. Peritoneal dialysis was not routinely
performed but was the preferred modality of dialysis or
fluid removal in the presence of renal insufficiency. Infants
with HLHS were managed according to a protocol previ-
ously described.11
Statistics. Student’s t test was used to compare length
of stay in premature versus term infants and very low-
birth-weight infants versus all others and to compare the
gestational age between survivors and nonsurvivors. The
Mann-Whitney rank sum test was used to compare age
and weight between survivors and nonsurvivors and length
of stay between patients who underwent type A versus
type B procedures. Fisher’s exact test was used to compare
survival in premature versus term infants. Confidence
intervals (CI) stated are equivalent to 1 standard deviation
of the point estimate.
Results
Mortality. Twenty-five patients survived to dis-
charge (hospital survival rate, 83%; CI, 76% to
90%). There was no statistically significant differ-
ence in age, weight, or gestational age in survivors
and nonsurvivors of the initial operation (Table II).
Three patients who underwent type A procedures
died, and two patients who underwent type B pro-
cedures died (p 5 0.6). Three infants died while
undergoing open cardiac procedures (mortality rate,
19%; CI, 9% to 29%), and two patients who under-
went closed heart operations died (mortality rate,
12%; CI, 4% to 20%). All five patients who died had
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been born prematurely; no deaths occurred in the
group of term, small-for-gestational-age infants.
Three of the infants who died had shunted single
ventricle physiology (mortality rate for patients with
this postoperative physiologic condition, 30%; CI,
16% to 44%), accounting for more than one half of
all deaths. Among 15 patients with separated pul-
monary and systemic circulations, only one death
occurred as the result of low cardiac output after an
arterial switch operation for TGA (mortality rate,
7%; CI, 1% to 13%). The smallest patient (1.1 kg)
had severe pulmonary disease before the operation
from a combination of severe congestive heart fail-
ure and hyaline membrane disease. This infant had
severe hypoxemia and hypercarbia after the opera-
tion and died in the operating room.
Length of stay. The length of stay for survivors of
the initial operation was 8 to 164 days (median, 57
days). The postoperative length of stay for these
patients was 6 to 122 days (median, 39 days). There
was no statistically significant difference between the
postoperative length of stay in infants who were
premature and appropriate for gestational age ver-
sus term, small-for-gestational-age infants nor in
those who underwent type A versus type B proce-
dures (Table III).
Ventilation. All patients were managed initially
as described earlier. Because of significant hypercar-
bia, two patients were placed on a Sechrist Infant
Ventilator model IV-100B (Sechrist Industries, Inc.,
Anaheim, Calif.) pressure-regulated ventilator. This
system may provide less dead space, allowing more
effective removal of carbon dioxide. There were no
other significant ventilation issues particular to the
patients’ size. The duration of mechanical ventila-
tion in survivors was 2 to 24 days (median, 6 days).
No patient underwent tracheostomy, and all survi-
vors were discharged without supplemental oxygen.
Open chests. Of the 33 surgical procedures, the
chest was left open electively at the conclusion of the
operation 13 times. All 13 patients with open chests
had open heart procedures. Chest closure was per-
formed in the pediatric cardiac intensive care unit 2
to 12 days (median, 5 days) after the initial opera-
tion. There were no complications related to having
an open chest. Mediastinal cultures were obtained
in all patients at the time of chest closure; none were
positive.
Infections. Blood cultures were positive in six
infants evaluated for septicemia. Isolated organisms
included Enterobacter cloacae, Enterococcus faecalis,
Staphylococcus aureus, and Pseudomonas aerugi-
nosa. Sterilization of the blood was documented in
all cases, and no infant died of sepsis.
Neurologic complications. Intraventricular hem-
orrhages were documented in five patients; one
additional patient had documented hydrocephalus.
It was not determined whether these complications
were present before the operation. Two additional
patients had seizures that were treated with anticon-
vulsants in the postoperative period.
Other complications. Thrombosis of the superior
vena cava was documented in two patients. One of
these patients had chronic chylous effusions that
persisted until his death 2 months after the opera-
tion. A complete atrioventricular block developed
Table II. Comparison of survivors and nonsurvivors
Survivors (n 5 25) Nonsurvivors (n 5 5) p Value
Median age (days) 20 (range, 1-140) 16 (range, 8-24) 0.9
Median weight (kg) 1.8 (range, 1.1-2.0) 1.8 (range, 1.1-2.0) 0.7
Median gestational age (wk) 33.5 (range, 28-40) 32 (range, 30-37) 0.8
Type A procedures (no. of patients) 19 3
Type B procedures (no. of patients) 6 2
Table III. Survival (CI) and median and quartiles for postoperative length of stay in survivors
Survival (%) p Value
Length of stay (days)
p ValueMedian 25%ile 75%ile
Weight # 1.5 kg 75 (60-90) 0.6 32.5 23 97 0.6
Weight . 1.5 kg 86 (79-93) 44 12.5 72
Gestational age # 37 wk 79 (71-87) 0.6 39 19.25 75.5 0.9
Gestational age . 37 wk 100 44 28.5 63
Type A procedure 86 (79-93) 0.6 44 17 78.25 0.3
Type B procedure 75 (60-90) 31 18 44
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in one patient after the repair of total anomalous
pulmonary venous return (TAPVR) and VSD,
which resulted in pacemaker placement before dis-
charge.
Operation in the very low-birth-weight infants.
Eight patients weighed 1.5 kg or less at operation.
Three patients had open heart operations, and five
patients had closed heart operations. Four proce-
dures were type A, and four procedures were type B.
Two deaths occurred in this group of patients. It
should be noted that successful reparative open
heart operation was achieved in two of these tiny
infants, one infant weighing 1.3 kg with obstructed
TAPVR and one infant weighing 1.5 kg with
TAPVR and VSD. However, this group did account
for four of the five patients with documented intra-
ventricular hemorrhages and the patient with hydro-
cephalus. Furthermore, the mean postoperative
length of stay in survivors from this group was 54.2
days versus 44.9 days in survivors weighing more
than 1.5 kg (p 5 0.6).
Follow-up. Of the 25 hospital survivors, 20 pa-
tients (80%; CI, 72% to 88%) are alive with a
follow-up of 1 to 63 months (mean, 13 months).
Kaplan-Meier analysis is provided in Fig. 1. All
survivors were considered to have good to excellent
cardiac status at the time of their last outpatient
visit, as judged by history, physical examination, and
echocardiography.
There were five late deaths of the 25 survivors of
the initial operation. One patient with TOF and
pulmonary atresia, status post placement of a mod-
ified Blalock-Taussig shunt as a newborn, died at 4
months of age on day 1 after operation for complete
repair. One child with truncus arteriosus and tri-
somy 18 died at 17 months of age of an episode of
aspiration after having a successful palliation as a
newborn and then repair at 10 months of age. One
patient with a TOF repair as a newborn died at 4
months of age from complications of biliary atresia.
One child appeared well palliated after a bidirec-
tional Glenn shunt for HLHS. A severe respiratory
infection developed in this child, who eventually
died of that illness. There was no evidence of chronic
lung disease in this child before her fatal illness. The
final late death occurred suddenly in a 4-month-old
infant who had pulmonary atresia with intact ven-
tricular septum and right ventricular–dependent
coronary circulation and who underwent a modified
Blalock-Taussig shunt in the newborn period.
Of the six surviving infants who underwent type B
procedures, four infants have subsequently under-
Fig. 1. Kaplan-Meier analysis for survival after heart operations in infants weighing 2 kg or less. Number
of patients at risk and CIs at selected points are also provided.
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gone successful repair of the defect. One patient
with coarctation and VSD initially underwent coarc-
tation repair, pulmonary artery banding, and subse-
quent VSD closure and debanding before discharge
because of inability to be weaned from the ventila-
tor. The remaining three patients underwent repair
at ages 6 to 23 months for TOF, truncus arteriosus,
and an atrioventricular canal defect. One 14-month-
old patient died in the postoperative period after
repair of TOF with pulmonary atresia. The last
patient to undergo a type B procedure is 9 months of
age after pulmonary artery banding for L-TGA with
VSD and is being observed for spontaneous closure
of the VSD.
Nine survivors underwent coarctation repair or
aortic arch reconstruction as part of their newborn
operation. Recoarctation with a gradient of 35 mm
Hg developed in one of these patients, who under-
went successful balloon dilation. The remaining
eight patients have gradients of less than 20 mm Hg
by blood pressure cuff and/or echocardiographic
estimates.
Discussion
The last 25 years have seen tremendous progress
in the surgical management of infants with congen-
ital heart defects. Advancements in technology and
forward thinking have led to an evolving philosophy
in management strategies. With each advancement,
the limitations to palliating or repairing congenital
heart defects in small infants diminish. As we push
the envelope of surgical management, younger and
smaller babies are undergoing heart operations.
The advent of alprostadil has been the most
significant therapy developed in the preoperative
management of newborns with ductus-dependent
congenital heart defects. Noninvasive imaging has
progressed to the level where most newborns do not
require cardiac catheterization for diagnostic pur-
poses,13 thereby eliminating associated risks. In fact,
no patient underwent cardiac catheterization before
the initial operation in this series. The importance of
obtaining cardiovascular stability and allowing for
the recovery of major organ system insults before
operation are now well-accepted philosophies. Dur-
ing the time period of this study, no infant in this
weight group was denied operation because of pre-
operative morbidity. Today’s patients are sent to the
operating room with better hemodynamic status and
with more accurate and detailed diagnoses than ever
before.
There has been substantial progress within the
operating room as well. Some of the most important
developments have been in the area of CPB tech-
niques.14-17 Equipment has been streamlined to
diminish hemodilution and priming volumes for
small infants. Concerns about the newborn’s ability
to handle the stresses of CPB have been replaced by
those concerning fetal bypass techniques.18 Surgical
modifications have led to improving survivals for
reparative congenital heart operations in newborns.
Evolving intraoperative strategies include the devel-
opment of hypothermic circulatory arrest, the devel-
opment of cold and warm cardioplegia techniques,
and a trend toward using low-flow CPB in infants
who are undergoing open cardiac operations.
There are significant advantages to a complete
repair rather than palliation in the small infant with
congenital heart disease. The neonatal heart has
been shown to be relatively noncompliant and less
capable of handling a volume load than the mature
heart.19, 20 The neonate may therefore be more
susceptible to morbidity associated with volume
overloading palliations (such as systemic–pulmonary
artery shunts) than older infants and children. Fur-
thermore, technical limitations exist in performing
systemic–pulmonary artery shunts in small infants.
The optimal size of these shunts to achieve ideal
acute and chronic systemic–pulmonary blood flow
ratios is not known. The possibility of significant
pulmonary overcirculation is therefore great with
larger shunts. Small shunts have the presumed in-
creased risk of occlusion from thrombosis and the
potential for significant distortion of the pulmonary
arteries. Elimination of cyanosis in infancy may also
have a beneficial effect on development.21 Finally,
once the palliation is performed, the complete re-
pair will still be necessary at some time. Whether the
risk of performing this repair at an older age is
diminished is uncertain.
Although it has been our philosophy to perform
complete repairs on neonates when possible, eight
patients in this series underwent palliations for
lesions that were reparable. One patient underwent
complete repair before discharge. Two patients had
TOF and diminutive pulmonary arteries initially
thought to preclude neonatal repair. Two patients
weighed 1.1 kg at operation. One patient had an
unbalanced atrioventricular canal defect in whom it
was unclear in infancy whether a biventricular repair
was possible. The final two patients were very early
in the series.
In our experience, managing the subgroup of
patients with univentricular physiologic condition
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was particularly difficult. However, small size did not
preclude survival. Although low-birth-weight infants
with single ventricle physiology may theoretically be
at increased risk because of an immature pulmonary
vascular bed, the results in this series do not justify
waiting to obtain an “ideal” minimal weight before
operation. In fact, prolonged exposure to a large
left-to-right shunt may increase the risk by increas-
ing the reactivity of the pulmonary vascular bed and
exposing the ventricle to a volume overload state
before operation.22
Eight infants with very low birth weights (#1.5 kg)
comprised 27% of the patients in the series. Certain
issues in the management of this subgroup are worth
noting. Most organ systems in this group of patients
are immature. Lack of skeletal calcium makes the
potential for clinically significant hypocalcemia with
low ionized serum calcium problematic.2 Tempera-
ture regulatory mechanisms are immature, leading
to occasional swings in core temperature with its
resultant problems.23 Renal and hepatic immaturity
make fluid management difficult and drug metabo-
lism and excretion erratic. Perhaps most importantly
in this population, cardiovascular immaturity, pul-
monary underdevelopment, and the immature pul-
monary vascular bed make the postoperative man-
agement of infants who are in a physiologically
transitional stage from fetus to neonate somewhat
unpredictable. The immature heart responds differ-
ently to loading conditions and is parasympatheti-
cally dominant with altered response to b-adrener-
gic stimulation.19, 20 The effects of ventilating
immature lung beds in the traditional manner (i.e.,
high tidal volumes) both acutely and chronically are
yet to be evaluated.23 The effects of manipulating
the developing pulmonary vascular bed with either
pharmaceutical or respiratory maneuvers have yet
to be described.24-27
The hospital survival in this series compares fa-
vorably with that reported in a series of 21 infants
weighing 2 kg or less who underwent major cardiac
operation from January 1985 to December 1989.28
The improved survival may in part be the result of
the current series occurring at a later time, taking
advantage of some of the advancements discussed
earlier. In the earlier series, there was a 100%
mortality rate for patients whose heart defect was
part of a recognizable syndrome. The coexistence of
a recognizable syndrome was not associated with
death in this series. In fact, there were no deaths in
the seven patients with a known, defined syndrome.
A study of neonates weighing less than 2.5 kg who
underwent open heart operations reported a hospi-
tal mortality rate of 16.5%,29 compared with 19% in
our series of open heart patients weighing 2.0 kg or
less. Hospital survival in the current series was
similar to that found in infants weighing less than 2.5
kg who underwent early intervention (i.e., either
surgical or transcatheter intervention during their
initial hospitalization).30 More than one half of that
group of 62 patients weighed more than 2.0 kg, and
23 of the 62 patients underwent palliative proce-
dures, making detailed comparisons to the current
series difficult.
Limitations. The limitations of this study are
primarily related to the retrospective nature of the
data collection. The gestational age of one infant
was unavailable. The sensitivity of detection of
recognizable syndromes and postoperative compli-
cations may be suboptimal. There is no discussion of
infants who were treated with transcatheter tech-
niques, those who were allowed to grow before the
operation, or those who died awaiting operation.
The results of this series should be applied only to
infants weighing 2.0 kg or less who have undergone
cardiac operation.
Conclusions
The physiologic limitations to open heart surgery
in small and frequently immature infants remains
uncertain. However, an aggressive surgical approach
in small infants with critical heart disease can be
associated with acceptable short- and medium-term
survival. The current series demonstrates that car-
diac operation in a selected group of infants 1.1 to
2.0 kg provides hospital survival similar to the early
experience in newborns weighing more than 2.0 kg.
Furthermore, in most instances, complete repair
was an attainable goal in such patients, with accept-
able survival and good cardiac status in the survivors
with medium-term follow-up. The long-term data
regarding neurologic outcome in this group is defi-
cient. Questions regarding the safety of CPB in
preterm, immature infants need to be addressed.
One must be particularly concerned with the devel-
oping germinal matrix that may be more susceptible
to neurologic complications from CPB. Further
investigation will consider the neurologic outcome
for this unique subgroup of infants.
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